PATENT CLAIM ANALYSIS

Application Number: 16379559
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["424", "009100"]

Abstract:
The present subject matter is directed to a method of manufacturing and purifying an intravenous injection of prothrombin complex concentration (PCC) from plasma Fraction III and a method of manufacturing and purifying an intravenous injection of non-PCC from plasma Fraction IV. The intravenous injection of PCC and non-PCC obtained from the method can be administered to a patient in need thereof for stopping replication, killing and preventing HIV-1 and HIV-2 in a patient.

Claim (Index 6):
The method of  claim 1 , wherein the weak anion exchange chromatography is conducted using DEAE A-50 at a final concentration of 4-10 wt %.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 100.0
- Lexical Diversity: 1.69565
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15090033', '15278699', '14056363', '13633057', '12842944']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7141700008923757
- 35 USC 102 Novelty (BERT): 0.57042567459662
- Combined Prediction Score: 0.6997955682628001
- Mean Citation Score: 220.655234
- Max Citation Score: 441.10236
- Similarity Product: 428.23954223618017

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test